|
|
|
Insider
Information: |
Love Richard L |
Relationship: |
Director |
City: |
San Antonio |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
122,528 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$670,121 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
122,528 |
|
|
Total
Value |
$670,121 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
PAREXEL International |
PRXL |
Director |
2017-09-29 |
0 |
2003-10-24 |
0 |
Premium* |
|
Imarx Therapeutics Inc |
SEGI |
Director |
2008-05-30 |
48,810 |
2007-07-26 |
0 |
Premium* |
|
Cti Biopharma Corporation |
CTIC |
Director |
2017-09-29 |
73,718 |
2007-09-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PRXL |
PAREXEL International |
officerTitle |
|
2005-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
29,500 |
|
- |
|
SEGI |
Imarx Therapeutics Inc |
Director |
|
2007-07-31 |
4 |
A |
$5.00 |
$75,000 |
D/D |
15,000 |
25,000 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2007-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
493,996 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
496,996 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2007-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
546,996 |
0 |
- |
|
SEGI |
Imarx Therapeutics Inc |
Director |
|
2008-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
23,810 |
48,810 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2008-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
555,996 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2008-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,307 |
65,307 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2008-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
80,600 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2009-01-07 |
4/A |
A |
$0.00 |
$0 |
D/D |
0 |
80,600 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2009-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,451,513 |
4,532,113 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2009-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
321,839 |
402,439 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2009-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
12,900 |
80,207 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2009-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
567,405 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2009-11-13 |
4 |
A |
$0.00 |
$0 |
D/D |
290,017 |
857,422 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2009-11-24 |
4 |
A |
$0.00 |
$0 |
D/D |
653,690 |
1,511,112 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2010-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
996,661 |
2,432,773 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2010-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,236 |
87,443 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2010-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
2,377,773 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2011-03-21 |
4/A |
A |
$0.44 |
$54,375 |
D/D |
125,000 |
2,352,773 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
8,412 |
100,030 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2011-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,333 |
395,461 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
187,292 |
582,753 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
516,360 |
933,004 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2012-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
27,415 |
960,419 |
0 |
- |
|
82 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|